SGMT vs TECH
Sagimet Biosciences Inc. Series A Common Stock (SGMT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
SGMT currently screens at market cap $403.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the SGMT and TECH stock pages for the full models.
Not investment advice.